Posted by Michael Wonder on 19 Aug 2024
New PBS listing for migalastat (Galafold) for the treatment of Fabry disease
19 August 2024 - On 1 September 2024, migalastat hydrochloride (Galafold) will become available on the PBS for the treatment of Fabry disease under certain circumstances.
Access to migalastat for new patients under the Life Saving Drugs Program will cease from 1 September 2024, with transition arrangements in place to facilitate access through the PBS for patients currently undergoing treatment.
